The NLRP3 inhibitor MCC950 suppressed myocardial infarction-induced NLRP3 inflammasome activation, alleviated cardiac inflammation and fibrosis, and improved cardiac function (Gao et al., 2019). Here, NLRP3 is linked to myocardial infarction.